Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TESTIGO: Quality of Life in Good Prognosis Metastatic Testicular Cancer
NCT07498959Recruiting
- Sponsor
- Sahlgrenska University Hospital
- Start
- Mar 2026
- Primary completion
- Mar 2031
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: Health-Related Quality of Life at 2 years. Started Mar 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07498959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07498959.